The data highlights the significant disparities in mortality rates from endocrine, nutritional, and metabolic diseases across countries. The United States leads with the highest mortality rate, followed by Mexico and Brazil. European countries like Germany and the UK have considerably lower rates, and the Nordic countries have the lowest rates globally. Recent trends from 2023 indicate increases in several countries, with Costa Rica, Colombia, and Croatia showing notable rises, whereas South Korea and Slovakia saw slight declines. The compound annual growth rate (CAGR) over the past five years indicates a consistent increase, especially in Peru, illustrating a concerning upward trend.
Future trends to watch include evolving healthcare policies, technological advancements, and lifestyle changes that may affect these mortality rates. Countries experiencing high growth rates in mortality might consider implementing public health interventions and innovations targeting prevention and better management of endocrine, nutritional, and metabolic diseases.
Top countries in Endocrine, Nutritional and Metabolic Diseases Mortality by Country
| # | 10 Countries | Units (Male Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 117,060 | 2023 | +9.56% | +10.65% | View data |
| 2 | 2 Mexico | 78,330 | 2023 | +4.22% | +6.84% | View data |
| 3 | 3 Brazil | 45,600 | 2023 | +1.29% | +3.77% | View data |
| 4 | 4 Germany | 17,700 | 2023 | +2.16% | +2.62% | View data |
| 5 | 5 South Africa | 14,000 | 2023 | +1.13% | +1.28% | View data |
| 6 | 6 Japan | 12,140 | 2023 | +0.97% | +0.64% | View data |
| 7 | 7 Colombia | 7,510 | 2023 | +2.69% | +8.96% | View data |
| 8 | 8 Peru | 7,100 | 2023 | +9.89% | +13.8% | View data |
| 9 | 9 United Kingdom | 6,940 | 2023 | +4.22% | +5.31% | View data |
| 10 | 10 Spain | 6,860 | 2023 | +0.99% | +3.05% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...